Epidemiology of dyslipidemia in Korea

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Cardiovascular disease is the leading cause of death worldwide and the second most common cause of death in Korea. Dyslipidemia is among the major modifiable risk factors for cardiovascular disease. To develop effective guidelines for the management of dyslipidemia, it is important to understand the epidemiologic characteristics of dyslipidemia in the target population. The prevalence of dyslipidemia in the Korean population has been reported variously from 30% to higher than 60%, but, in general, the prevalence of dyslipidemia among Koreans has been increasing. Among the subtypes of dyslipidemia, hypercholesterolemia and hyper-LDL cholesterolemia are relatively uncommon in Korea compared to other high-income countries. On the other hand, hypertriglyceridemia and hypo-HDL cholesterolemia are very common in Korea. Recent data shows that total and LDL cholesterol levels are increasing in the Korean population, while triglyceride and HDL cholesterol levels have not been changing. As a consequence, the prevalence of hypercholesterolemia and hyper-LDL cholesterolemia is increasing. These data reinforce the need to make a greater effort toward the prevention and treatment of dyslipidemia.

Original languageEnglish
Pages (from-to)352-357
Number of pages6
JournalJournal of the Korean Medical Association
Volume59
Issue number5
DOIs
Publication statusPublished - 2016 May

Fingerprint

Korea
Dyslipidemias
Epidemiology
Hypercholesterolemia
Cause of Death
Cardiovascular Diseases
Hypertriglyceridemia
Health Services Needs and Demand
LDL Cholesterol
HDL Cholesterol
Population
Triglycerides
Guidelines

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{6db9f01edced449baf543e0b2e7ab76a,
title = "Epidemiology of dyslipidemia in Korea",
abstract = "Cardiovascular disease is the leading cause of death worldwide and the second most common cause of death in Korea. Dyslipidemia is among the major modifiable risk factors for cardiovascular disease. To develop effective guidelines for the management of dyslipidemia, it is important to understand the epidemiologic characteristics of dyslipidemia in the target population. The prevalence of dyslipidemia in the Korean population has been reported variously from 30{\%} to higher than 60{\%}, but, in general, the prevalence of dyslipidemia among Koreans has been increasing. Among the subtypes of dyslipidemia, hypercholesterolemia and hyper-LDL cholesterolemia are relatively uncommon in Korea compared to other high-income countries. On the other hand, hypertriglyceridemia and hypo-HDL cholesterolemia are very common in Korea. Recent data shows that total and LDL cholesterol levels are increasing in the Korean population, while triglyceride and HDL cholesterol levels have not been changing. As a consequence, the prevalence of hypercholesterolemia and hyper-LDL cholesterolemia is increasing. These data reinforce the need to make a greater effort toward the prevention and treatment of dyslipidemia.",
author = "Kim, {Hyeon Chang}",
year = "2016",
month = "5",
doi = "10.5124/jkma.2016.59.5.352",
language = "English",
volume = "59",
pages = "352--357",
journal = "Journal of the Korean Medical Association",
issn = "1975-8456",
publisher = "Korean Medical Association",
number = "5",

}

Epidemiology of dyslipidemia in Korea. / Kim, Hyeon Chang.

In: Journal of the Korean Medical Association, Vol. 59, No. 5, 05.2016, p. 352-357.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Epidemiology of dyslipidemia in Korea

AU - Kim, Hyeon Chang

PY - 2016/5

Y1 - 2016/5

N2 - Cardiovascular disease is the leading cause of death worldwide and the second most common cause of death in Korea. Dyslipidemia is among the major modifiable risk factors for cardiovascular disease. To develop effective guidelines for the management of dyslipidemia, it is important to understand the epidemiologic characteristics of dyslipidemia in the target population. The prevalence of dyslipidemia in the Korean population has been reported variously from 30% to higher than 60%, but, in general, the prevalence of dyslipidemia among Koreans has been increasing. Among the subtypes of dyslipidemia, hypercholesterolemia and hyper-LDL cholesterolemia are relatively uncommon in Korea compared to other high-income countries. On the other hand, hypertriglyceridemia and hypo-HDL cholesterolemia are very common in Korea. Recent data shows that total and LDL cholesterol levels are increasing in the Korean population, while triglyceride and HDL cholesterol levels have not been changing. As a consequence, the prevalence of hypercholesterolemia and hyper-LDL cholesterolemia is increasing. These data reinforce the need to make a greater effort toward the prevention and treatment of dyslipidemia.

AB - Cardiovascular disease is the leading cause of death worldwide and the second most common cause of death in Korea. Dyslipidemia is among the major modifiable risk factors for cardiovascular disease. To develop effective guidelines for the management of dyslipidemia, it is important to understand the epidemiologic characteristics of dyslipidemia in the target population. The prevalence of dyslipidemia in the Korean population has been reported variously from 30% to higher than 60%, but, in general, the prevalence of dyslipidemia among Koreans has been increasing. Among the subtypes of dyslipidemia, hypercholesterolemia and hyper-LDL cholesterolemia are relatively uncommon in Korea compared to other high-income countries. On the other hand, hypertriglyceridemia and hypo-HDL cholesterolemia are very common in Korea. Recent data shows that total and LDL cholesterol levels are increasing in the Korean population, while triglyceride and HDL cholesterol levels have not been changing. As a consequence, the prevalence of hypercholesterolemia and hyper-LDL cholesterolemia is increasing. These data reinforce the need to make a greater effort toward the prevention and treatment of dyslipidemia.

UR - http://www.scopus.com/inward/record.url?scp=84969760753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969760753&partnerID=8YFLogxK

U2 - 10.5124/jkma.2016.59.5.352

DO - 10.5124/jkma.2016.59.5.352

M3 - Review article

AN - SCOPUS:84969760753

VL - 59

SP - 352

EP - 357

JO - Journal of the Korean Medical Association

JF - Journal of the Korean Medical Association

SN - 1975-8456

IS - 5

ER -